I wonder if we will see any results on next stage trials before end of this quarter. They seemed to be indicating dosing of foot ulcer or UTI would commencce this quarter, cant recall which or if it was both. Either way it would be great if we could get an update showing another indication that has actually bee treated and hopefully cleared/ significantly improved in real world human infection. I wonder if they have to wait for Ethics approval to start either new trial, I would assume so and that might cause delays.
Either way to date we have had news that a sinusitis patient was sucessfully treated under emergency access, and early burns data indicated chronic burns infections were being cleared in 7 days. Would be great to get another indication of efficacy in human infection.
RCE Price at posting:
68.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)